Table 3.
Absolute count of patients being prescribed particular cART drug combinations overall by calendar year
| |
2007 |
2008 |
2009 |
2010 |
2011 |
|---|---|---|---|---|---|
| ( n = 636 ) | ( n = 1274 ) | ( n = 1758 ) | ( n = 1787 ) | ( n = 1846 ) | |
| d4T/3TC/NVP |
456 (71.7%) |
955 (74.9%) |
1080 (61.4%) |
826 (46.2%) |
674 (36.5%) |
| d4T/3TC/EFV |
62 (9.7%) |
105 (8.2%) |
132 (7.5%) |
81 (4.5%) |
65 (3.5%) |
| AZT/3TC/NVP |
11 (1.7%) |
71 (5.5%) |
92 (5.2%) |
150 (8.4%) |
297 (16%) |
| AZT/3TC/EFV |
217 (34.1%) |
370 (29%) |
654 (37.2%) |
609 (34%) |
641 (34.7%) |
| TDF/FTC/EFV |
0 |
0 |
84 (4.8%) |
431 (24.1%) |
600 (32.5%) |
| ABC/ddI/LPV/r / ABC/ddI/SQV/r | 6 (0.95%) | 18 (1.4%) | 18 (1%) | 22 (1.2%) | 33 (1.7%) |
Data is presented as count (column percentage). In case of >1 regimen per year per patient, multiple counts per patients were included in one year. Total number (n) represents sum of patients per year, not sum of regimen counts listed. Column percentages were denominated using n.